Hepcortespenlisimut-L

N/A

Report date: 2024/10/22 20:00:07

Base Information

Drug NameHepcortespenlisimut-L
Drug Alias NameV-5 ImmunitorHepko-V5V-5
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLiver CirrhosisLiver NeoplasmsCarcinoma, Hepatocellular +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineMongolia
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmunitor Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLiver CirrhosisLiver NeoplasmsCarcinoma, Hepatocellular +[4

Other Information

ATC CodeN/A
Related LinksN/A